Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02904265 · ClinicalTrials.gov registry record · Phase 2
Efficacy Study of Acetazolamide Versus Diazepam in Continuous Spike and Wave/Landau-Kleffner Syndrome
A Phase 2 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT02904265: Clinical Trial Phase 2 study, sponsored by Mayo Clinic.
NCT02904265 is a Phase 2 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02904265, a Phase 2 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of the medications acetazolamide and diazepam in the treatment of continuous spike wave in sleep (CSWS) and Landau-Kleffner syndrome (LKS).
Interventions
- DRUG Acetazolamide
- DRUG Diazepam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-09 |
| Est. Completion | 2019-07-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02904265
The ClinicalTrials.gov registry entry for NCT02904265 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetazolamide is the first listed.
NCT02904265 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02904265 about?
NCT02904265 is a clinical study titled "Efficacy Study of Acetazolamide Versus Diazepam in Continuous Spike and Wave/Landau-Kleffner Syndrome". The purpose of this study is to compare the effectiveness of the medications acetazolamide and diazepam in the treatment of continuous spike wave in sleep (CSWS) and Landau-Kleffner syndrome (LKS).
What is the current status of trial NCT02904265?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2016-09. Estimated completion is 2019-07-26.
What interventions are being tested in trial NCT02904265?
The interventions under investigation include: Acetazolamide (DRUG), Diazepam (DRUG).
Who is sponsoring clinical trial NCT02904265?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.